Welcome to our dedicated page for Lifevantage news (Ticker: LFVN), a resource for investors and traders seeking the latest updates and insights on Lifevantage stock.
LifeVantage Corporation (Nasdaq: LFVN) is a health and wellness company centered on nutrigenomics and cellular activation, and its news flow reflects this focus. The company regularly issues updates on its activator-based product portfolio, consultant community, scientific research, and participation in investor and industry events. As the Activation company, LifeVantage highlights how its products, such as the Protandim family, TrueScience Liquid Collagen, the MindBody GLP-1 System, and the comprehensive gut activator P84, fit into broader wellness systems and scientific narratives.
News about LifeVantage often covers new product launches and enhancements, including additions to its activation-supporting nutrients, AXIO nootropic energy drink mixes, and TrueScience skin and hair care line. Company communications also describe major field events like Momentum Academy and Global Kickoff, where Consultants receive training, hear about new tools, and learn strategies related to enrollment, retention, and advancement. These events frequently coincide with the introduction of new offerings or the integration of acquired product lines such as LoveBiome’s P84.
Investors following LFVN can also expect announcements on quarterly and annual financial results, dividend declarations, share repurchase activity, and guidance ranges, as well as notices of participation in conferences and fireside chats. The company’s releases include commentary from management on strategic initiatives such as integrating LoveBiome assets, expanding its wellness ecosystem, and advancing digital capabilities like the Daily Activation app.
This news page aggregates these updates so readers can track developments in LifeVantage’s product science, consultant network, and corporate strategy in one place. For anyone monitoring LFVN stock, the consultant-driven business model, or trends in nutrigenomics-focused wellness products, the news feed provides an ongoing view of how the company communicates its progress and priorities.
LifeVantage (Nasdaq: LFVN) has announced a significant update to its Rewards Circle Customer loyalty program in the U.S., Australia, and New Zealand markets. The refresh introduces new benefits for both Consultants and Customers, aiming to enhance engagement and provide greater value. Consultants will now enjoy free shipping on enrollment orders with scheduled future Subscriptions and receive business-building rewards for each Subscription shipment. Customers will benefit from first-Subscription perks, including free shipping and gifts for orders above a certain threshold, as well as lower redemption thresholds for Reward Credits.
This update comes 16 months after the program's initial launch in March 2023 as part of LifeVantage's LV360 initiatives. The enhancements were driven by Customer retention data and aim to make Subscriptions more attractive for Consultants looking to grow their business.
LifeVantage (Nasdaq: LFVN) is hosting virtual 'LifeVantage Open House' calls on July 23 and 24, 2024, to showcase its recent transformation initiatives, innovative compensation plan, and award-winning products. The July 23 call will feature a Q&A with company executives, including CEO Steve Fife, and board member Erin Brockovich. They will discuss the company's evolution and positioning for future growth in direct sales.
The July 24 call will highlight experiences of LifeVantage sales leaders, including members of the Field and Scientific Advisory Boards. They will share insights on the company's products, the Evolve Compensation Plan, and why it's an exciting time to be a LifeVantage Consultant. Both calls are scheduled for 6:00 PM MT and are open to anyone interested in learning more about LifeVantage's health and wellness offerings and business opportunities.
LifeVantage (Nasdaq: LFVN) hosted its global Activate 2024 virtual event on July 20, 2024, reaffirming its commitment to the direct selling industry. The event highlighted the company's transformation and focus on modern direct selling through its LV360 initiative. CEO Steve Fife teased a major product launch set for October 2024 - an innovative weight loss product designed to suppress food cravings and balance hunger hormones through cellular activation.
The event emphasized the company's Rise ERA strategy (Enrolling, Retaining, and Advancing), showcasing positive impacts on Consultant performance. LifeVantage also announced its 2024 Incentive Trip - an 8-day Alaskan cruise for top achievers from the US, Canada, Mexico, and Europe. The event included comprehensive sales training sessions led by top leaders, providing strategies aligned with Rise ERA principles.
LifeVantage (Nasdaq: LFVN) announced that its President and CEO, Steve Fife, and CFO, Carl Aure, will participate in two investor conferences in June 2024. They will present at the Water Tower Research Consumer Products Virtual Investor Conference on June 5 at 11:00 am ET, and the MicroCap Rodeo – Spring Into Summer Conference on June 6 at 2:00 pm ET in New York City. Both presentations will be available via live webcast and for replay on LifeVantage’s Investor Relations website for approximately 90 days.
LifeVantage (LFVN) will participate in the Sidoti Micro Cap Conference on May 8-9, 2024. The President, CEO, and CFO will present to investors. The webcast will be available on the company's Investor Relations website.
LifeVantage (Nasdaq:LFVN) declared a quarterly cash dividend of $0.04 per share, reflecting a 14.3% increase from the previous quarter. The dividend will be paid on June 14, 2024, to stockholders of record as of May 31, 2024.
LifeVantage reported financial results for the third quarter of Fiscal 2024 with revenue of $48.2 million, a 10.2% decrease from the prior year. Adjusted EBITDA increased by 54.7% to $5.1 million. Despite revenue declines in the Americas and Asia/Pacific & Europe, positive trends were seen in operating margins and productivity gains. The company repurchased shares and announced a cash dividend of $0.04 per share. Fiscal Year 2024 guidance projects revenue of $202-$205 million and adjusted EBITDA of $16-$18 million.
Summary not available.
Summary not available.
Summary not available.